Atlas Trials

Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination

Clinical trial NCT04842305 · UNKNOWN

Trial details

NCT number
NCT04842305
Sponsor
Lenanrt Friis-Hansen
Status
UNKNOWN
Study type
OBSERVATIONAL
Covid19
Start date
2021-04-01
Primary completion
2021-05-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.